» Articles » PMID: 37475861

Potential Value of Neuroimmunotherapy for COVID-19: Efficacies and Mechanisms of Vagus Nerve Stimulation, Electroacupuncture, and Cholinergic Drugs

Overview
Journal Front Immunol
Date 2023 Jul 21
PMID 37475861
Authors
Affiliations
Soon will be listed here.
Abstract

COVID-19 is an inflammatory disease with multiple organs involved, mainly respiratory symptoms. Although the majority of patients with COVID-19 present with a mild to moderate self-limited course of illness, about 5-10% of patients with inflammatory disorders in severe COVID-19 have life-threatening progression. With the exception of a few drugs that have shown outstanding anti-COVID-19 effects, the efficacy of most drugs remains controversial. An increasing number of animal and clinical studies have shown that neuromodulation has a significant effect on reducing inflammatory markers of COVID-19, thus exerting an effective neuroimmunotherapeutic value. Currently, the main neuroimmunomodulatory measures effective against COVID-19 include vagus nerve stimulation, electroacupuncture, and cholinergic drugs. In this review, we will summarize the research progress of potential value of this neuroimmunotherapy measures for COVID-19 and elaborate its efficacies and mechanisms, in order to provide reliable evidence for clinical intervention.

References
1.
Baez-Pagan C, Delgado-Velez M, Lasalde-Dominicci J . Activation of the Macrophage α7 Nicotinic Acetylcholine Receptor and Control of Inflammation. J Neuroimmune Pharmacol. 2015; 10(3):468-76. PMC: 4546521. DOI: 10.1007/s11481-015-9601-5. View

2.
Laws M, Surani Y, Hasan M, Chen Y, Jin P, Al-Adhami T . Current Trends and Future Approaches in Small-Molecule Therapeutics for COVID-19. Curr Med Chem. 2020; 28(19):3803-3824. PMC: 7611096. DOI: 10.2174/0929867327666200721161840. View

3.
Kaniusas E, Kampusch S, Tittgemeyer M, Panetsos F, Gines R, Papa M . Current Directions in the Auricular Vagus Nerve Stimulation I - A Physiological Perspective. Front Neurosci. 2019; 13:854. PMC: 6697069. DOI: 10.3389/fnins.2019.00854. View

4.
Wang Y, Pereira E, Maus A, Ostlie N, Navaneetham D, Lei S . Human bronchial epithelial and endothelial cells express alpha7 nicotinic acetylcholine receptors. Mol Pharmacol. 2001; 60(6):1201-9. DOI: 10.1124/mol.60.6.1201. View

5.
Nadwa E, Al-Kuraishy H, Al-Gareeb A, Elekhnawy E, Albogami S, Alorabi M . Cholinergic dysfunction in COVID-19: frantic search and hoping for the best. Naunyn Schmiedebergs Arch Pharmacol. 2022; 396(3):453-468. PMC: 9735034. DOI: 10.1007/s00210-022-02346-9. View